Therefore, the exact screening of DNA-binding molecules is indispensable to evaluate using the amount of only one specific target gene.
In the present communication, we evaluate the DNA-binding affinities of chemical compounds using PD templates with a real-time PCR analyzer. This strategy suppresses amplification of non-specific PCR products, resulting in enabling us to evaluate exact DNA-binding affinities of chemical compounds by PCR efficiency. The procedure is schematically shown in Fig. 1 . First, PD templates are obtained by conventional PCR techniques without any templates. After the addition of analytic samples into a PCR solution with PD templates, the PCR efficiency was monitored using a real-time PCR analyzer. When analytes had a DNA-binding capacity, the stability of PD templates increased. As a result, the PCR efficiency decreased because the denatures of PD templates adducted with DNA-binding molecules become difficult in the denature step. On the other hand, the PCR efficiency was not changed when non-DNA-binding molecules were added into the PCR solution. Thus, the existence or non-existence of DNA-binding affinities of the chemical compounds can be detected by monitoring the fluorescence profiles associated with amplification of the target DNA. The biggest feature of this work is that PDs prepared in advance are employed as templates. Additionally, to suppress the amplification of non-specific PCR products, the denature temperature is set to around the melting temperature of the PD templates. Under the unique PCR conditions, the PCR products derived from the PD templates are only amplified exponentially, while the production of other non-specific PCR products is suppressed, because of the difficulty to denature from ds DNA to single-stranded DNA at lower melting temperatures. Therefore, we can obtain exact information about the DNA-binding affinities of chemical compounds.
For materials used in this work, we prepared PD templates and PCR product templates using a conventional PCR technique. 
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Japan) were mixed in a single tube on a 100-μL scale. For PCR product templates derived from human K-ras ongogene (codon 59-99), 1 ng plasmid DNA (ras Mutant Set c-Ki-ras codon 12, Takarabio, Otsu, Japan) and PCR solution described above were mixed in a single tube. Gene amplification was performed in each PCR solution. After preheating the PCR solution at 95 C for 10 min, 40 cycles were performed using steps of 94 C for 30 s, 55 C for 30 s, and 72 C for 30 s in a thermocycler (icycler; Bio-Rad, California, USA). The PCR solution was kept at 72 C for 7 min, and then cooled. For the purification step of PDs or PCR products, a spin column (BioFynamics Laboratory, Inc., Tokyo, Japan) was used and adjusted with TE buffer to 10 pg/μL.
To accurately measure the DNA-binding affinity of chemical compounds with the real-time PCR analyzer, the suppression of non-specific PCR products is indispensable in a PCR solution containing DNA-binding molecule. Before the determination of DNA-binding affinity of chemical compounds using a real-time PCR analyzer, we compared the amplified PCR products using PD templates and those using PCR product templates in a PCR solution containing a DNA-binding molecule. As a model of a DNA-binding molecule, 4′,6-diamidino-2-phenylindole (DAPI) was used. We prepared various concentrations of DAPI with PCR solutions; test solution contained 0, 250, 500, or 1000 nM DAPI. Each test solution was incubated at room temperature for 30 min, and then target genes in each PCR tube were amplified in a thermal cycler. The cycle conditions were as follows: X C (30 s), 55 C (30 s), 72 C (30 s) for 40 cycles. X represents the melting temperature of templates. In detail, X was 75 C for PD templates or 82 C for PCR product templates, respectively. Cycling was started after an initial denaturation at X C for 10 min. Then, we analyzed the PCR products using a microchip electrophoresis device (Agilent 2100 bioanalyzer with DNA 1000 LabChips; Agilent Technology, CA). When DAPI was added into PCR solution, the amplifications of the target genes were suppressed in all test solutions, as shown in Fig. 2 . Critically, when PDs were used as templates, the non-specific PCR products were not amplified in PCR solution containing DAPI (Fig. 2a) . On the other hand, the amplifications of target genes were suppressed by favoring non-specific amplification of shorter products when PCR products were used as templates to determine the DNA-binding affinities of DAPI, as shown in Fig. 2b . These results show that PD templates are suitable to determine the DNA-binding affinities of chemical compounds with a real-time PCR analyzer because the exact measurement of DNA-binding affinity is necessary to evaluate using the amount of only one specific target genes using SYBR Green I dye system. This strategy also enabled the screening of DNA-binding molecules with high sensitivity, because the target genes as signal were amplified by PCR. We confirmed the capability of the method by changing the incubation time from 30 min to 12 h, and the amount of the template DNA from 10 pg to 0.1 pg. We utilized 0.135 × SYBR Green I to detect the amplifications of the target genes. The fluorescence intensity associated with the amplified target DNA was monitored in each PCR tube using a real-time PCR analyzer (Stratgene; Agilent Biotechnology, USA). Figure 3 shows the results of the amplified efficiency with the target DNA in each PCR solution containing 0, 5, 10 and 50 nM DAPI. Reproducible determinations of 10 nM DAPI (300 fmol) were confirmed. These results indicate that the strategy has a sensitivity greater than any existing DNA-binding screening system. The method has great potential to correspond to screening valuable minute samples obtained through multiple chemical steps and microfluidic-synthesized chemical components.
In conclusion, we have developed a unique screening strategy for DNA-binding molecules using PCR efficiency with a real-time PCR analyzer. Using the PDs as template DNA, the DNA-binding affinity of chemical compounds allows us to detect without disturbing the fluorescence intensities derived from non-specific PCR products. Moreover, the DNA-binding affinities of chemical compounds were determined with high sensitivity. The screening method also has several advantages over previously reported instrumental screening methods: (1) the utility of a real-time PCR analyzer brings in parallel with the screening of DNA-binding molecules, because the real-time PCR analyzers have parallel 96 or 384 reaction wells; (2) the experiment procedure is very simple because test compounds are only mixed in the PCR solution containing SYBR Green I without the need of the TaqMan probes or molecular beacon probes. We believe that the strategy will be a powerful tool for screening chemical compounds in drug discovery.
